# Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

> **NCT00309855** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 80 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Placebo
- **DRUG:** Testosterone
- **DRUG:** Anastrazole
- **DRUG:** Dutasteride

## Key facts

- **NCT ID:** NCT00309855
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309855, "Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00309855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*